RICHMOND – The Virginia General Assembly delivered a strong victory for families across the Commonwealth by passing House Bill 431, which extends the expiration date of the Alzheimer’s Disease and Related Disorders Commission from July 1, 2026, to July 1, 2029. The measure, sailed through both chambers with near-unanimous support, highlighting a rare moment of unity in addressing a critical health challenge facing seniors and their loved ones.

Prefiled on January 12, 2026, and ordered printed the following day, HB431 quickly gained traction in the House. Referred to the House Rules Committee on January 12, it was assigned to the Studies Subcommittee on January 22. The subcommittee recommended reporting the bill on January 23 with a unanimous 5-0 vote. The full Rules Committee followed suit on January 27, reporting it out 18-0. The House read the bill for the first time on January 29, passed second reading and engrossed it on January 30, and gave final approval on February 2 with a resounding 99-0 block vote.

The bill then moved to the Senate, where it was referred to the Senate Rules Committee on February 3. The Senate dispensed with first reading that day. On February 27, the Senate Rules Committee reported it with a substitute (26108867D-S1) by a 14-0 vote. The Senate read it a third time on March 3, agreed to the Rules substitute, and passed the engrossed version on a 40-0 block vote. Procedural steps, including suspending rules and dispensing with second reading constitutional requirements, were handled efficiently with voice or block votes.

Returning to the House on March 5, members agreed to the Senate substitute by a 97-1 vote, effectively passing the legislation. A fiscal impact statement from the Department of Planning and Budget was issued on January 13, ensuring lawmakers had full transparency on any budgetary implications before advancing the bill.

The Alzheimer’s Disease and Related Disorders Commission plays a vital role in Virginia’s response to the growing prevalence of Alzheimer’s and related dementias. Established as an advisory body within the executive branch, its purpose centers on assisting individuals living with these conditions and their caregivers. Comprising 15 members, the commission works to foster a dementia-capable Virginia, coordinating efforts across agencies to provide ethical, person-centered support. This extension ensures the commission can continue its essential work without interruption, maintaining momentum on initiatives like the Dementia State Plan.

The overwhelming bipartisan backing, particularly the unanimous committee votes led by Republican members in key positions, demonstrates fiscal prudence and a commitment to practical governance. Rather than creating new bureaucracy, HB431 simply renews an existing entity proven effective in supporting families. House Rules Committee members, including strong conservative voices, propelled the bill forward 18-0, reflecting confidence in its targeted approach. Senate Rules followed with their own 14-0 endorsement, underscoring broad agreement on prioritizing senior care.

In Virginia, where family caregivers shoulder significant burdens, this commission extension preserves vital resources and coordination. The swift passage through the General Assembly— from prefiling to final concurrence in under two months—exemplifies efficient legislative action on issues that matter most to everyday Virginians. With the bill now headed to the Governor’s desk, its enactment will secure three additional years of dedicated focus on Alzheimer’s, reinforcing protections for vulnerable populations and upholding values of responsibility and compassion.

This legislative success comes at a time when Alzheimer’s affects thousands of Virginia households, straining families and healthcare systems. By extending the commission, lawmakers affirm the importance of sustained, coordinated strategies to mitigate the disease’s impact. The near-perfect vote tallies in both chambers signal robust confidence in the commission’s track record and future contributions. As the bill awaits gubernatorial action, it stands as a testament to the General Assembly’s ability to deliver results on pressing public health priorities.